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Abstract
Background: Bovine tuberculosis (bTB) caused by Mycobacterium bovis is the most serious endemic disease affecting
livestock in the UK. The European badger (Meles meles) is the most important wildlife reservoir of bTB transmission to
cattle, making eradication particularly difficult. In this respect, oral vaccination with the attenuated M. bovis vaccine Bacillus
Calmette-Guerin (BCG) has been suggested as a wide-scale intervention to reduce bTB infection in badgers. However,
experimental studies show variable protection. Among the possibilities for this variation is that the resident gut bacteria
may influence the success of oral vaccination in badgers; either through competitive exclusion and/or inhibition, or via
effects on the host immune system. In order to explore this possibility, we have tested whether typical gut commensals
such as Lactic Acid Bacteria (LAB) have the capacity to impact on the viability and survival rate of BCG and to modulate
the immune response to BCG using an in vitro model.
Results: Twelve LAB isolated from badger faeces displayed inhibitory activity to BCG that was species-dependent.
Weissella had a bacteriostatic effect, whereas isolates of enterococci, lactobacilli and pediococci had a more bactericidal
activity. Furthermore, BCG-induced activation of the pro-inflammatory transcription factor NF-κB in human THP-1
macrophages was modulated by LAB in a strain-dependent manner. Most pediococci enhanced NF-κB activation but
one strain had the opposite effect. Interestingly, isolates of enterococci, lactobacilli and weissella had different effects as
immunomodulators of BCG-induced macrophage responses as some had no significant influence on NF-κB activation,
but others increased it significantly.
Conclusions: Our in vitro results show that LAB isolated from badgers exhibit significant inhibitory activity against BCG
and influence the immune activation mediated by BCG in a human macrophage assay. These findings suggest that gut
commensal bacteria could play a role in influencing the outcome of oral BCG vaccination. Inactivated cells of LAB, or
LAB that are bacteriostatic but have a synergistic immunostimulatory effect with BCG, could be potential adjuvants to
be used for oral vaccination in badgers. Further work is needed to take into account the complex nature of the gut
microbiome, specific immunity of the badger and the in vivo context.
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Background
Bovine tuberculosis (bTB) caused by Mycobacterium
bovis is the most serious endemic disease affecting live-
stock in England and Wales [1]. Scientific evidence sug-
gests that the European badger (Meles meles) is one of
the most significant wildlife reservoirs of M. bovis in
parts of the UK and Ireland [2]. The cases of bTB infec-
tion across England and Wales appear to occur more
frequently in regions with higher densities of badgers
[3], which have led both governments to implement
comprehensive control strategies, including tighter cattle
movement controls, biosecurity measures, culling and
vaccination of badgers [4].
Biosecurity measures intended to keep badgers and
cattle apart can be hard to implement at pasture [5]. In
this respect, vaccination with the attenuated M. bovis
vaccine Bacillus Calmette-Guerin (BCG) could be a vi-
able alternative to control M. bovis infection in badgers
[6]. However, the use of injectable BCG is limited and
expensive due to the need to trap animals in order to
vaccinate them [7, 8]. Oral BCG vaccination could bring
the prospect of a wider-scale implementation and has
been reported to reduce not only bTB infection in bad-
gers but also their susceptibility to infection [9, 10].
However, protection with oral BCG is variable, at least
in experimental models [11]. Although the reasons for
this variability in protection have not been accounted for
conclusively, one possibility could be the influence of
gut resident bacteria on the efficacy of orally adminis-
tered BCG due to competitive exclusion and/or inhib-
ition in the gut; or after uptake by the oral mucosa; or
through direct and indirect effects on immune cells [12]
.
The composition of the mammalian intestinal micro-
flora varies considerably over time and between individ-
uals [13], and badgers are likely to be no different.
Therefore, we sought to focus on Lactic Acid Bacteria
(LAB) for the purposes of our initial investigations. LAB
are gut commensal bacteria that provide a beneficial ef-
fect on intestinal epithelial cells in numerous ways: they
metabolize indigestible compounds; provide the host
with essential nutrients; contribute to the development
of the intestinal architecture; and prevent against
colonization of opportunistic pathogens [14]. It is very
well documented that LAB produce antimicrobial com-
pounds such as organic acids, hydrogen peroxide, etha-
nol and bacteriocins [15], which can be active against a
broad range of bacteria including mycobacteria [16, 17].
Furthermore, LAB are key to maintaining the intestinal
microbial balance in mammals, as well as to generate
beneficial host immunomodulation [13]. The gut im-
mune system recognizes LAB via the ligation of
microbe-associated molecular patterns (MAMPs) to pat-
tern recognition receptors (PRRs) such as Toll-like
receptors (TLRs) that are expressed on immune cells
and epithelial cells [18]. Upon MAMP recognition, PRRs
activate an intracellular signalling cascade converging on
the pro-inflammatory transcription factor NF-κB, which
is crucial in maintaining immune homeostasis and regu-
lating immunological and anti-microbial responses in
barrier tissues such as the intestine [19]. Therefore, LAB
play a role in innate immune responses and modulate
responses to oral vaccination [20].
The aim of this study was to isolate LAB naturally ex-
creted by badgers in order to identify those isolates that
display inhibitory activity to BCG and assess their ability
to modulate BCG-mediated pro-inflammatory responses
in an established surrogate macrophage model. LAB iso-
lated from badger faeces were initially screened for in-
hibitory activity against non-pathogenic Mycobacterium
smegmatis, with a total of 40 LAB showing this activity.
From these isolates, 12 were selected to be most repre-
sentative and co-cultured with BCG to evaluate their an-
tagonistic influence on the viability and survival rate of
BCG. To study their potential as immunodulators, the
human macrophage line THP-1 was exposed to the 12
LAB strains in isolation and in the presence of BCG,
and the inflammatory responses recorded in the form of
NF-κB activation and TNF-α production. Our results
demonstrate that numerous LAB isolated from badgers
have the capacity to reduce the viability and survival of
BCG in vitro and to modulate the immune response of
human THP-1 macrophages exposed to BCG. These
fundamental findings suggest that gut commensal bac-
teria could play a role in influencing the outcome of oral
BCG vaccination in badgers. In this respect, in vivo work
will be needed to further explore this possibility.
Results
Isolation of LAB from badgers with antimycobacterial
activity
A total of 40 LAB isolated from badger faeces showed
antimicrobial activity against Mycobacterium smegmatis
and were identified as enterococci, lactobacilli, pedio-
cocci and weissella (Figure 1). At this stage M. smegma-
tis was used as a fast-growing mycobacteria species to
facilitate rapid antimycobacterial screening [21]. As indi-
cated in Table 1, these 40 isolates with antimicrobial ac-
tivity against M. smegmatis were randomly distributed
between sexes and the weight of the badgers and/or the
absolute or relative total counts observed on selective
agar plates for LAB (De Man, Rogosa, Sharpe, MRS) and
total viable counts (Plate Count Agar, PCA).
Viability of BCG in combination with LAB
Twelve out the 40 LAB isolates with antimycobacter-
ial activity were selected to test their influence on the
fitness of BCG (referred as BCG viability in this
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study). These twelve LAB isolates were: 1, Entero-
coccus faecalis A7; 2, Weissella cibaria A23; 3, W.
paramesenteroides A37; 4, Pediococcus pentosaceus
B4; 5, E. faecalis C34; 6, Lactobacillus reuterii D4; 7,
P. acidilactici E24; 8, P. lolii F7; 9, P. acidilactici I32;
10, P. acidilactici M17; 11, W. paramesenteroides
N43; and 12, L. plantarum P5; which represented
four different genera – Enterococcus, Weissella, Pedio-
coccus and Lactobacillus - with two strains of the
same genus and/or species from at least two different
animals, as well as two or more different strains
within the most predominant genus and/or species.
The 12 selected isolates were then cultured with a
BCG strain carrying a Green Fluorescence Protein
(GFP) expression vector in order to monitor the
fluorescence emission for 48 h (h), as a marker of cell
viability. E. coli and Salmonella were also co-cultured
with BCG to provide results with other typical
fast-growing enteric bacteria. As illustrated in Fig-
ure 2., all LAB isolates reduced BCG viability signifi-
cantly after 24 and 48 h, especially isolates of
enterococci and weissella. No significant differences
were observed in the E. coli co-cultures after 48 h,
nor with Salmonella at either time point (24 or 48 h),
demonstrating that the activity was specific to LAB
and not due to trivial factors, such as competition for
nutrients with other faster-growing bacteria.
Fig. 1 Agar-well Diffusion Test showing the antimicrobial activity of cell-
free supernatants collected from cultures of 40 LAB isolated from
badgers against M. smegmatis. These 40 isolates were identified by 16S
rRNA sequencing and named as: (1) Pediococcus acidilactici A5; (2) P. lolii
A6; (3) Enterococcus faecalis A7; (4) Weissella cibaria A23; (5) W.
paramesenteroides A37; (6) P. pentosaceus B4; (7) P. acidilactici B41; (8) P.
lolii B53; (9) E. faecalis C34; (10) Lactobacillus reuterii D4; (11) P. acidilactici
E12; (12) P. lolii E23; (13) P. acidilactici E24; (14) P. acidilactici E48; (15) P. lolii
F7; (16) P. acidilactici F20; (17) P. acidilactici F24; (18) P. acidilactici F44; (19)
E. faecalis F48; (20) P. lolii G23; (21) P. pentosaceus G24; (22) P. acidilactici
G41; (23) E. faecalis G42; (24) P. lolii G54; (25) P. acidilactici H33; (26) E.
faecalis H34; (27) P. acidilactici I32; (28) E. faecium I47; (29) L. plantarum J2;
(30) P. acidilactici J26; (31) P. acidilactici L4; (32) P. acidilactici M16; (33) P.
acidilactici M17; (34) W. paramesenteroides N43; (35) E. faecium O44; (36) L.
plantarum P5; (37) P. acidilactici Q16; (38) L. plantarum R20; (39) L.
plantarum S48; (40) L. plantarum T17. All supernatants showed very
acidic pH ranging between 3.6–-4.0 for lactobacilli and pediococci, and
4.2–-4.5 for weissella and enterococci. MRS broth (MRS) and supernatants
from cultures of L. lactis NZ9700 (700) and L. lactis NZ9800 (800) were
used as controls. Both L. lactis strains reduce pH in MRS but no lower
than pH 4.5
Table 1 Total counts of microaerophilic bacteria and bacterial
isolates displaying antimycobacterial activity from faecal samples
of the 26 badgers selected for this study
Badgers: Total Counts: Isolates with
antimycobacterial
activityf
ICa Sexb Weight (Kg) MRSc PCAd MRS:PCAe
A f 8.3 5.61 5.56 1.14 5, 6, 7, 8, 23, 37
B m 10.1 5.98 5.93 1.12 4, 41, 53
C f 8.2 6.36 6.38 0.96 34
D m 10.2 7.54 7.61 0.85 4
E f 7.5 5.72 5.71 1.02 12, 23, 24, 48
F m 12.1 7.32 6.34 9.54 7, 20, 24, 44, 48
G f 9.1 7.46 6.45 10.35 23, 24, 41, 42
H f 8.8 6.70 6.40 2.00 33, 34
I f 11.5 6.08 6.26 0.67 32, 47
J f 10.7 5.38 5.40 0.96 2, 26
K f 10.1 7.92 7.76 1.43 –
L f 8.8 8.86 8.87 0.97 4
M m 12.3 8.45 8.43 1.04 16, 17
N m 8.4 8.95 8.08 0.75 43
O f 8.0 8.76 8.87 0.78 44
P m 10.8 8.38 8.53 0.71 5
Q f 8.4 8.72 8.87 0.72 16
R f 8.8 8.13 8.15 0.96 20
S m 9.9 7.66 7.65 1.02 48
T f 10 7.41 7.32 1.24 17
U m 10.5 8.23 8.40 0.68 –
V m 9 8.48 8.51 0.94 –
W f 10 7.46 6.86 4.03 –
X m 10 7.96 6.94 10.46 –
Y m 12.4 7.08 6.56 3.33 –
Z m 9.9 7.94 7.49 2.8 –
AA m 9.1 7.93 6.92 10.24 –
AB f 8.8 7.72 6.04 4.82 –
aIdentification code
bFemale (f) or Male (m)
cTotal counts on MRS agar plates expressed as log10
dTotal counts on PCA plates expressed as log10
eTotal Counts ratio between MRS and PCA plates
fIsolates from MRS that display antimicrobial activity against M. smegmatis on
a stab-on-agar test. These isolates were named with the numbers indicated in
the column and preceded with a letter from their corresponding animal IC
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Survival of BCG in combination with LAB
The survival of BCG when co-cultured with LAB, E. coli
or Salmonella, was determined by total bacterial counts.
With the exception of the weissella isolates, all the LAB
combinations resulted in a significant reduction in BCG
survival (Figure 3); being particularly evident in the case
of the lactobacilli isolates and most of the pediococci.
Neither the weissella, E. coli nor Salmonella had a sig-
nificant effect on the BCG counts. Taken together with
the results for GFP expression, we have shown that iso-
lates of enterococci, lactobacilli and pediococci reduce
significantly the viability and survival of BCG, whereas
co-cultures with weissella or enterobacteria do not. We
next sought potential explanations for these results;
whether altered pH or metabolites from LAB could ac-
count for the results we observed.
Effect of pH on BCG with or without LAB
The pH of the co-cultures described above was moni-
tored over 48 h. A significant decrease in pH was re-
corded in all co-cultures after 24 and 48 h but no
significant differences were observed between cultures,
including LAB, E. coli and Salmonella (Additional file 1:
Figure S1). The only exception was isolate P5 after 24 h
for reasons that remain unknown. Furthermore, both
the viability (GFP expression) and survival rate (bacterial
counts) of BCG as a monoculture showed no significant
changes at pH 7 or pH 5 after 24 and 48 h (Additional
file 1: Figure S2). With the exception of isolate P5, all
these results confirm that low pH may be insufficient on
its own to cause a detrimental effect on BCG.
Effect of metabolites from LAB on the viability and
survival rate of BCG
In order to test whether the antimicrobial effects ob-
served against BCG in the presence of LAB was due
to an accumulation of toxic metabolites from LAB,
we monitored the viability and survival rate of BCG
in cell-free supernatants obtained from mono-cultures
of LAB after 48 h of incubation. Supernatants taken
from 48 h cultures of E. coli and Salmonella were
also used as controls. No significant reductions were
observed with any of the culture supernatants, either
in terms of viability or as survival rate (Additional file
1: Figure S3 and S4, respectively). This demonstrated
that the negative effect of LAB on BCG was only ob-
served when the bacteria were present together, rather
than through the indirect accumulation of antimicro-
bial metabolites derived from the LAB, such as or-
ganic acids (e.g. lactic acid).
Fig. 2 BCG viability when combined with badger isolates of enterococci (i), weissella (ii), lactobacilli (iii) and pediococci (iv) after 0 (white bars), 24
(grey bars) and 48 (black bars) h of incubation. Co-cultures of BCG with gut-associated, Gram-negative bacteria (v) were also monitored for comparative
purposes. BCG viability is expressed as log10 Relative Fluorescence Units (RFU). Data are mean ± SD with statistical analysis (Student’s t-test, *p < 0.05, **p
< 0.01, ***p < 0.005) and are representative of 3 biological replicates each
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NF-κB response in macrophages exposed to LAB
To study the effect of LAB on NF-κB activation we
employed THP-1 macrophages carrying a NF-κB lucifer-
ase reporter as a model system. Cells were differentiated
with phorbol 12-myristate 13-acetate (PMA) for 48 h
and subsequently exposed to the 12 LAB isolates. We
assessed NF-κB responses at 100 bacteria per macro-
phage, a dose that had been previously observed to trig-
ger activation by LAB (data not shown). We found that
exposure to inactivated weissella and enterococci isolates
did not trigger NF-κB luciferase activation. However, a
significant increase in the reporter activity was recorded
upon exposure to pediococci and lactobacilli isolates
(see white bars in Figure 4). Interestingly, activation was
strain-specific. Isolates P. pentosaceus B4, P. acidilactici
I32 and L. plantarum P5 showed a low NF-κB activation
that is directly comparable to that observed with the hu-
man probiotic L. plantarum WCFS-1, with no signifi-
cant differences between them. By contrast, isolates P.
acidilactici E24, E. faecalis F7 and P. acidilactici M16
displayed a significantly higher pro-inflammatory effect
by comparison with WCFS-1 (p < 0.05), with a moderate
NF-κB luciferase activation as observed for LPS at
0.2 μg/mL. Interestingly, isolate L. reuterii D4 induced a
NF-κB response that was as high as that observed with
other bacteria associated with a high pro-inflammatory
profile such as E. coli and a BCG Pasteur strain, with no
significant differences between them. We then assessed
activation of the NF-κB-driven luciferase at different
time points (6, 12 and 24 h post-exposure) and doses
(100, 10 and 1 bacteria per macrophage) with three rep-
resentative LAB (low, medium, and high NF-κB induc-
tion) (Figure 5). In all cases, LAB activated NF-κB in a
dose-dependent manner.
Production of TNF-α in macrophages exposed to LAB
To confirm that the NF-κB activation observed by the
luciferase reporter led to a production of an inflamma-
tory cytokine, the levels of tumour necrosis factor alpha
(TNF-α) were measured in the medium of macrophages
exposed to LAB. TNF-α is a critical NF-κB-dependent
cytokine commonly found as a host inflammatory
marker in response to bacteria [22]. PMA-differentiated
THP-1 cells were exposed to 100 bacteria per macro-
phage for 24 h and supernatants were tested in an
anti-TNF-α ELISA. TNF-α production correlated posi-
tively with NF-κB activation (Additional file 1: Figure
S5). Enterococci and weissella were unable to induce any
TNF-α production, whereas pediococci and lactobacilli
mediated variable amounts of TNF-α production (black
bars in Figure 4). These results confirmed not only that
the pro-inflammatory role of our LAB isolates is
Fig. 3 BCG survival rate when combined with badger isolates of enterococci (i), weissella (ii), lactobacilli (iii) and pediococci (iv) after 0 (white
bars), 24 (grey bars) and 48 (black bars) h of incubation. Co-cultures of BCG with gut-associated, Gram-negative bacteria (v) were also monitored
for comparative purposes. BCG survival is expressed as log10 CFU/mL. Data are mean ± SD with statistical analysis (Student’s t-test, *p < 0.05, **p
< 0.01, ***p < 0.005) and are representative of three biological replicates each
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dependent on the species but also that isolates of pedio-
cocci and lactobacilli induce variable pro-inflammatory
levels in a strain-specific manner.
Influence of LAB on BCG-induced NF-κB activation
In order to test whether LAB isolates had a significant ef-
fect on the response of macrophages to BCG, we moni-
tored NF-κB changes in macrophages exposed to a BCG
Pasteur strain in combination with each of our LAB iso-
lates. BCG is a potent activator of NF-κB and exposure to
PMA-differentiated THP-1 cells for as little as 6 h is suffi-
cient to detect significant changes in NF-κB reporter ac-
tivity, either alone or in combination with LAB, especially
at a ratio of 10 LAB per 1 BCG (Figure 6). Thus, we stud-
ied the effect of LAB on BCG-mediated NF-κB activation
at a ratio of 100:10:1 (LAB:BCG:macrophage) after 6 h of
co-incubation. In order to facilitate data interpretation,
the results obtained from the macrophages exposed to the
LAB-BCG combinations were divided into two groups
based on the intensity of the pro-inflammatory profile of
the LAB isolates on their own (Figure 7). Most LAB iso-
lates with no, or very little, effect on NF-κB activation had
a negligible impact on BCG-induced reporter activity (Fig-
ure 7a). However, isolates E. faecalis C34 and W. parame-
senteroides N43, which had no effect on the NF-κB
response in isolation for even 24 h (Figure 4), significantly
increased NF-κB activation when combined with BCG.
On the other hand, nearly all the isolates that clearly acti-
vated the NF-κB pathway on their own significantly en-
hanced the pro-inflammatory response of macrophages
when combined with BCG (Fig. 7b). The exceptions were
isolates P. acidilactici E24 and L. plantarum P5. Both P5
and E24 increased NF-κB activation when incubated in
isolation with macrophages for 24 h (Fig. 4), but this was
not observed after 6 h of co-incubation with BCG. The
BCG-induced response remained unaffected by P5, but
was surprisingly reduced by E24 and this was statistically
significant.
Fig. 4 NF-κB activation (white bars) and TNF-α production (black bars) in PMA-differentiated THP-1 macrophages exposed to inactivated cells from
LAB isolates of weissella, pediococci, enterococci and lactobacilli at a ratio of 1 macrophage per 100 bacteria for 24 h. NF-κB activation is presented as
a fold increase over a non-stimulated condition on the primary Y axis (left hand), while TNF-α production is presented in ng/mL on the secondary Y
axis (right hand). Lactobacillus plantarum WCFS-1, E. coli K12, BCG and LPS at 0.2 μg/mL were included as controls
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Discussion
This is the first publication reporting the isolation and
identification of LAB from faeces of badgers. Previous
works have reported only a single LAB isolate from the
intestine of a badger [23] or a LAB population detected
in faeces of other mustelids [24]. In our study we show
that different LAB species isolated from different bad-
gers can exert in vitro inhibitory activity against M.
smegmatis and M. bovis BCG. The effect of the LAB iso-
lates seems to be species-dependent. The weissella iso-
lates only reduced BCG viability as measured by GFP
expression, but had no significant effect on the survival
Fig. 5 NF-κB activation in PMA-differentiated THP-1 macrophages exposed to inactivated cells of Lactobacillus plantarum P5, Pediococcus lolii F7 and
Lactobacillus reuterii D4 at a bacteria:macrophage ratio of 100:1 (black dots); 10:1 (grey dots); or 1:1 (white dots) for 24 h. NF-κB activation is presented
as a fold increase over a non-stimulated condition and the selected LAB strains represent a low (P5), moderate (F7), and high (B4) NF-κB response in
THP-1 macrophages. Data represent at least two biological replicates
Fig. 6 NF-κB activation in PMA-differentiated THP-1 macrophages exposed to inactivated cells of Lactobacillus reuterii D4, BCG and combinations of D4
with BCG (D4:BCG) for 24 h. When the bacteria were tested on their own, macrophages were exposed to bacteria at a bacteria:macrophage ratio of
100:1 (black dots); 10:1 (grey dots); and 1:1 (white dots); for the D4:BCG combinations, the macrophages were challenged with bacteria at a
LAB:BCG:macrophage ratio of 100:100:1 (back dots); 100:10:1 (grey dots); and 100:1:1 (white dots). NF-κB activation is presented as a fold increase over
a non-stimulated condition and data represent at least two biological replicates
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rate of BCG as measured by bacterial counts, suggesting
a more bacteriostatic, rather than bacteriocidal, effect. In
contrast, isolates of enterococci, lactobacilli and pedio-
cocci displayed a bactericidal effect since they were cap-
able of reducing significantly both the viability and
survival rate of BCG.
We suspected that the activity that our LAB isolates dis-
played against M. smegmatis were due to the combination
of acidic pH and metabolites such as lactic acid [25]. How-
ever, low pH and accumulation of organic acids, either
alone or in combination, were insufficient to induce a de-
crease in the viability and survival of M. bovis BCG when
grown as a monoculture or in acidic cell-free supernatants
from LAB. Our finding is in agreement with a previous
study that reported that M. bovis tolerates low pH and or-
ganic acids; being able to survive and remain virulent in
very acidic environments such as cheese [26]. Interest-
ingly, the 12 LAB isolates selected in our study caused a
significant reduction in the viability and the survival of
BCG when cultured together in vitro. These results are
consistent with two previous studies that reported a re-
duction in M. bovis counts in co-cultures with LAB in
milk [27, 28]. We also observed that this significant BCG
reduction only took place when BCG and LAB were
present in cultures together, suggesting the direct inhib-
ition of BCG by LAB, rather than an indirect effect due to
acidic conditions or the accumulation of toxic metabolites
derived from LAB. Whether this inhibition is due to anti-
microbial metabolites that are only produced in the pres-
ence of BCG is a question that remains to be elucidated.
However, other studies have reported that the efficacy of
LAB metabolites against bacterial pathogens is more evi-
dent when competing simultaneously in the same envir-
onment [29]. The relevance of our findings depends on
the extent to which opportunities exist in vivo for resident
LAB and orally administered BCG vaccine to come into
intimate contact with one another. This is currently un-
known and would need to be tested using more complex
model systems, such as in vitro organ culture models.
Nonetheless, LAB may still contribute to a gastric envir-
onment that is not conducive to BCG survival.
The reasons why our LAB isolates differ in their activity
against BCG may lie in the differing metabolic profiles of
the isolates. Weissella are obligate heterofermenters, able
a
b
Fig. 7 NF-κB activation in PMA-differentiated THP-1 macrophages exposed to inactivated cells from badger LAB isolates with no (or very low) pro-
inflammatory (a) or pro-inflammatory (b) profile, in the absence (white bars) or presence (black bars) of BCG at a ratio of 100:10:1 (LAB:BCG:macrophage)
for 6 h. A medium-only condition (RPMI) was included as a control. Comparative statistical analysis was carried out between BCG and all the LAB-BCG
combinations using the Student t-test (*p < 0.05, **p < 0.01, ***p < 0.005). Data are mean ± SD representing three biological replicates each
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to produce not only lactic acid as the major end product
from energy metabolism but also other metabolites such
as acetic acid and ethanol [30]. The remainder of the iso-
lates produce lactic acid as the main end product since
they are obligate or facultative heterofermenters [31]. The
amount of lactic acid produced by the isolates in vitro
may change depending on the oxygen availability, but this
organic acid seems to have a key role as the main anti-
microbial metabolite. Besides, strains of pediococci, en-
terococci and lactobacilli have been reported to produce
antimicrobial peptides such as pediocins [32], enterocins
[33] and plantaricins [34], as well as reuterin [35], which
could act synergistically with lactic acid against BCG.
Oral administration of probiotics has been suggested
as a convenient and safe way to improve the efficacy of
conventional vaccines within communities [36]. Surface
and/or secreted proteins and metabolites of LAB act as
inflammatory mediators, interacting with cells of the
mammalian immune system to stimulate and modify im-
munity [37–39], typified by activation of the NF-κB
pathway in macrophages. Whilst studies are relatively
limited in the context of oral vaccination, it would ap-
pear that efficient activation of the NF-κB pathway fol-
lowing oral immunisation results in strong systemic
immunity [40]. Much of the research on the role of pro-
biotics in the immune response has been conducted with
lactobacilli, but other studies using other LAB that are
in close contact with the mucus layer and epithelial
crypts of the small intestine such as enterococci and
pediococci, have also demonstrated an immune modula-
tion that enhanced vaccine efficacy [41–43]. Therefore,
we wanted to determine the impact that different badger
LAB isolates had on the inflammatory response, on their
own, and in the context of BCG vaccination.
In this study we have observed that inactivated cells of
pediococci and lactobacilli induce NF-κB activation and
TNF-α production in the human THP-1 macrophage cell
line. On the contrary, inactivated cells of weissella and en-
terococci had no effect either on the NF-κB pathway or on
TNF-α production. As previously reported by Jensen et al.
[38], our Lactobacillus reuterin isolate induced the highest
pro-inflammatory response, withTNF-α production, whereas
L. plantarum was a much lower inducer, as observed with
the human probiotic L. plantarum WCFS-1. When com-
pared to E. coli and BCG, the pediococci isolates induced a
moderate pro-inflammatory response in THP-1 macro-
phages. This response was observed to be strain-dependent
as some of the isolates were much higher inducers than
others. More detailed studies are needed to fully understand
the pro-inflammatory effect of pediococci but a recent study
has reported that exopolysaccharides from a Pediococcus
pentosaceus strain induce the production of pro-inflam
matory cytokines via NF-κB [44]. Furthermore, our experi-
ments with inactivated cells of enterococci did not show any
NF-κB activation although heat-killed enterococci can acti-
vate the NF-κB pathway in murine macrophages [39]. This
difference could be explained by the fact that our bacteria
and macrophages derive from strains and species that are
different to the previous work.
Combinations of BCG with inactivated cells from almost
all our lactobacilli and pediococci resulted in enhanced
NF-κB activation, or at least, in a non-detrimental effect
on this pro-inflammatory pathway. On the basis of other
work [45], it is possible this is effect is mediated through
TLR-2. The only exception was P. acidilactici E24, which
induced NF-κB activation in isolation, but reduced the ex-
tent of activation triggered by BCG. Takata et al. reported
that P. acidilactici inoculation in mice suppressed the pro-
duction of inflammatory cytokines, whilst increasing the
number of interleukin (IL)-10-producing T cells [46]. It is
well-known that IL-10 and other anti-inflammatory cyto-
kines have the capacity to modulate NF-κB activation [47].
Further investigation is required to determine whether the
effects observed for P. acidilactici in mice also occur in
badgers.
Although inactivated cells of weissella and enterococci
were unable to cause any pro-inflammatory activation in
THP-1 macrophages, co-cultures of certain strains with
BCG resulted in a synergistic enhancement of NF-κB re-
sponses. Previous studies have reported that heat-killed
weissella and E. faecalis proteins block the secretion of
pro-inflammatory cytokines and attenuate NF-κB activa-
tion [48, 49], but also that lipoteichoic acids of weissella
and enterococci significantly increase the secretion of
pro-inflammatory cytokines and contribute to host in-
flammatory responses [48, 50]. Therefore, there could be
a significant variability between weissella and entero-
cocci strains, with some of them able to modulate the
outcome of BCG-induced inflammatory responses; pos-
sibly via TLR2, as both LAB and BCG activate macro-
phages in a TLR-2-dependent manner [37, 45].
Despite the fact that we did not use monocytes from
badgers, our model has proved to be informative; gener-
ating preliminary data that show the potential for
badger-derived LAB to cause immunomodulation, either
alone or in combination with BCG. This now needs to
be tested using macrophages isolated from badgers. In
addition, although the mechanisms that our isolates
utilize as immunomodulators remain to be elucidated,
our data also raise the interesting possibility of their po-
tential exploitation as adjuvants to BCG if used as inacti-
vated cells.
Conclusions
We started from the premise that the variation and activ-
ity of commensal gut bacteria could play an important,
and hitherto underappreciated role in the outcome of oral
BCG vaccination in badgers. We found that LAB isolated
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from badger faeces could influence the viability of BCG
vaccine in vitro and modify the pro-inflammatory re-
sponse using an established macrophage-like model.
These preliminary results, although generated from reduc-
tionist in vitro assays, suggest our premise is worthy of
further investigation. More extensive evaluation of the
badger gut microbiome and its impact on the efficacy of
oral vaccination in vivo appears warranted.
Methods
Badgers and sampling
Faecal samples were collected from a total of 26 badgers
kept in captivity at the Animal Plant and Health Agency
for other scientific projects authorised under a UK
Home Office Project Licence and Ethical approval by
the Agency. These badgers were initially taken from a
bTB-free wild population and they all tested negative to
M. bovis infection following a quarantine procedure that
consisted of bTB testing on three sequential occasions.
The TB testing was carried out at approximately one
month intervals using the badger interferon (IFN)-γ ELI-
SPOT, the badger specific IFN-γ release assay (IGRA)
and a standard M. bovis culture with clinical samples.
Three negative tests were required before an animal was
considered free of bTB and admissible to the study. All
the badgers were on a diet that mainly consisted of com-
mercial dog food with no probiotics, a very high source
of carbohydrates from wholegrain maize and wheat
(58%), a high source of protein from fish (20%), a low
level of fat (7%) -most of it as polyunsaturated fatty
acids; and enriched with fibre (4%) and essential vita-
mins and minerals. The badgers were also provided with
commercial dry dog food (no LAB in its composition),
peanuts, apples and sweet chestnuts, when available, as
well as any food from foraging activities such as insects,
worms and mice. Fresh water was available ad libitum.
Faecal samples were taken from badgers using rectal
swabs following intramuscular administration of keta-
mine hydrochloride (10 mg/kg, Vetalar, Boehringer
Ingelheim), medetomidine hydrochloride (0.1 mg/kg,
Domitor, Pfizer), and butorphanol (0.1 mg/kg, Torbuge-
sic R, Zoetis UK Ltd) as described previously [11]. Bad-
gers were then weighed, examined for any signs of
disease or injury and their corresponding sex noted to
ascertain whether these factors could affect the different
levels of LAB found in the collected faecal samples.
Isolation of LAB from faecal samples
The rectal swabs were immersed in maximum recovery di-
luent (Oxoid) to prepare serial dilutions that were spread
onto MRS agar plates (Oxoid) for the isolation of LAB. The
serial dilutions were also spread onto PCA plates (Oxoid)
to estimate the percentage of LAB when compared to total
microaerophilic viable bacteria. Plates were incubated at
37 °C for 48–60 h under microaerophilic conditions. A total
of 50 different colonies were then selected from MRS-agar
plates containing approximately 20–100 colonies from each
of the 26 collected faecal samples (a total of 1300 colonies),
and cultivated in Thermo Scientific Nunc MicroWell™
96-well plates with MRS broth at 37 °C for 48–60 h under
microaerophilic conditions.
Antimycobacterial screening of LAB
The supernatants of the MRS cultures present in the
96-well plates were tested against Mycobacterium
smegmatis mc2 155 [51] using the spot-on-agar test.
Briefly, the 96-well plates were centrifuged for 10 min
at 5000 rpm to deposit 5 μL of the culture superna-
tants on TSA plates which had been swabbed with
M. smegmatis. The MRS cultures whose supernatants
showed antimicrobial activity against M. smegmatis
were selected to confirm their antimycobacterial activ-
ity using the Agar-well Diffusion Test (ADT) [52].
The nisin-producer Lactococcus lactis NZ9700 and its
corresponding knock-out strain NZ9800 were used as
positive and negative controls, respectively [53].
Bacterial strains and growth conditions
All LAB, including the badger isolates and the human
probiotic L. plantarum WCFS-1 [54], were grown in
MRS broth/agar (Oxoid) at 37 °C without any aer-
ation for 24 h. The L. lactis strains NZ9700 and
NZ9800 [55] were also grown static in MRS for 24 h
but at 30 °C. The strains E. coli ATCC25922, E. coli
K12 [56] and S. enterica ATCC14028 were propagated
in Trypticase Soy Broth/Agar (TSB/TSA, Oxoid) at
37 °C for 24 h. M. smegmatis mc2 155 was also cul-
tured in TSB at 37 °C but supplemented with 0.05%
Tween 80 (Sigma Aldrich) and for 48 h. The two M.
bovis strains BCG ΔleuD pASOriMXF [57] and BCG
Pasteur [58] were cultured in Middlebrook 7H9
(Difco) supplemented with 10% Oleic acid albumin
dextrose-catalase (OADC) enrichment (BD BBL™),
0.1% Tween 80 (Sigma Aldrich) and 0.2% glycerol
(Sigma Aldrich) or Middlebrook 7H11/7H10 (Difco)
medium supplemented with 5% OADC and glycerol
(2 mL/L) at 37 °C. BCG ΔleuD pASOriMXF was previ-
ously generated by transforming BCG Pasteur ΔleuD
with the mycobacterial episomal vector pASOriMXF
that complements the leucine mutation to correct
auxotrophy and enable stable expression of GFP
under the control of the constitutively expressed pro-
moter pL5X [59]. All enterobacteria and mycobacteria
were grown with aeration in an orbital shaker at
225 rpm and all bacterial strains were maintained as
− 80 °C frozen stocks in their appropriate media with
the addition of 15% glycerol.
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Identification and selection of LAB with antimycobacterial
activity
Colonies from MRS cultures whose anti-mycobacterial
activity was confirmed by ADT were identified based on
their morphology (small, circular, white/creamy col-
onies), gram staining (positive) and oxidase/catalase tests
(negative). Further identification was carried out by 16S
rRNA gene sequencing (LGC Genomics) before a final
selection of the 12 most representative LAB species
comprising different bacterial species isolated from dif-
ferent animals but also different strains representing the
most predominant bacterial species found.
Co-cultures of BCG and LAB
Cell pellets of the selected LAB and the leucine auxo-
trophic strain BCG ΔleuD pASOriMXF were obtained
from cultures at their exponential phase of growth. The
auxotrophy correction allowed us to perform co-cultures
of LAB and BCG without using antibiotics while main-
taining the GFP plasmid to monitor BCG viability over
time. In order to prepare the co-cultures, 12 BCG pellets
were resuspended with each LAB pellet using
Mueller-Hinton (MH) broth supplemented with 10%
Oleic acid-Albumin-Dextrose-Catalase (OADC) enrich-
ment, 0.1% Tween 80 and 0.2% glycerol, to generate 12
co-cultures at an initial concentration of 5 × 103 CFU/
mL for BCG and 5 × 105 CFU/mL for the LAB. Our own
preliminary studies showed that MH broth supple-
mented with OADC, tween and glycerol is the optimal
to support the growth of LAB without altering the via-
bility and survival rate of BCG for 48 h when grown as
mono-cultures. The co-cultures were then grown in an
orbital shaker at 37 °C for 48 h and samples were col-
lected at 0, 24 and 48 h post-incubation to determine
BCG viability and survival rate. Co-cultures of BCG with
the enterobacteria E. coli (ATCC 25922) and S. enterica
serovar Typhimurium (ATCC 14028) at an initial con-
centration of 5 × 105 CFU/mL were also included in the
study for comparative purposes.
Viability and survival rate experiments
In order to monitor BCG viability in the co-cultures, ali-
quots of 100 μl were transferred into Thermo Scientific
Nunc MicroWell™ 96-well plates to measure fluorescence
emission at 485/535 nm in a DTX 880 Multimode De-
tector microplate reader (Beckman Coulter). Simultan-
eously, BCG survival rate was determined by total
bacterial counts on BCG-selective agar plates (Middleb-
rook 7H10 supplemented with 5% OADC and 0.2% gly-
cerol). Bacterial counts were also carried out for LAB and
the enterobacteria on their corresponding selective agar
plates: MRS and Violet Red Bile Glucose (Oxoid), respect-
ively. BCG viability was expressed as log10 RFU (Relative
Fluorescence Units), where measured fluorescence units
(FU) were multiplied by the log10 increase in the CFU/mL
of the competitor and normalized with the highest in-
crease in CFU/mL observed for any of the competitors.
These relative units let us compare GFP expression be-
tween the co-cultures at each time point over 48 h since
the bacterial counts varied amongst the LAB and entero-
bacteria (Additional file 1: Figure S6). The BCG survival
rate was presented as CFU/mL.
pH in co-cultures
The pH of all co-cultures was measured using a Hanna
pH meter at time points 0, 24 and 48 h, starting from an
initial pH of 7 for the media, to determine the effect of
pH on the viability and survival of BCG while
co-cultured with LAB. The viability and survival rate of
BCG was also monitored at pH 7 and pH 5 as explained
above but as a monoculture to evaluate the influence of
pH on the growth of BCG.
Metabolite accumulation experiments
In order to determine the effect of LAB metabolites on
BCG growth, cell pellets of BCG ΔleuD pASOriMXF were
resuspended in cell-free supernatants collected from 48 h
cultures of LAB, E. coli ATCC25922 and S. enterica
ATCC14028 to monitor viability, and survival rate as ex-
plained above. The BCG survival rate was indicated as
CFU/mL and the viability as log10 FU (Fluorescence Units).
Culture and differentiation of THP-1 cells
The THP-1 Lucia™ NF-κB monocyte cell line (Invivogen)
was used to monitor the NF-κB signal transduction
pathway in macrophages when exposed to inactivated
cells obtained from the badger LAB isolates. These mac-
rophages secrete Lucia luciferase under the control of
the NF-κB promoter. The cells were grown in Roswell
Park Memorial Institute (RPMI) 1640 (Life Technolo-
gies) supplemented with 15% foetal bovine serum (FCS,
Seralab) and 1% Penicillin/Streptomycin (Pen/Strep, Life
Technologies) at 37 °C in an atmosphere of 5% CO2.
PMA (Santa Cruz Biotechnology) was dissolved in
DMSO at 10 mg/mL. 5 × 104 cells per well were seeded
in with RPMI supplemented with 20 ng/mL PMA in
Thermo Scientific Nunc MicroWell™ 96-well plates.
After 48 h, medium was replaced with RPMI containing
2% FCS and 1% Pen/Strep supplemented with inacti-
vated cells of LAB.
Luciferase measurements from THP-1 cells exposed to
LAB
PMA-differentiated THP-1 cells were exposed to
heat-inactivated (70 °C, 2 h) LAB pellets that were resus-
pended in RPMI containing 2% FCS and 1% Pen/Strep.
At the indicated times, supernatants were transferred to
white-bottom 96-well plates and luciferase activity was
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measured in the presence of 2 μg/mL of coelenterazine
(NanoLigh Technology) using a Clariostar plate reader
(BMG Biotech). The BCG Pasteur strain, E. coli K12 and
L. plantarum WCFS1, all as inactivated cells, were used
as controls, as well as LPS at 0.2 μg/μl (Sigma Aldrich).
The BCG Pasteur strain was also used to test whether
LAB isolates had a significant effect on the response of
macrophages to BCG. NF-κB activation was calculated
as a fold increase over the measurements recorded for
unchallenged macrophages.
ELISA for TNF-α detection
TNF-α production was detected and quantified in the
supernatants of PMA-differentiated THP-1 cells using
the eBioscience Human TNF-α ELISA Ready-SET-Go
kit as indicated by the manufacturer’s instructions.
Statistical analysis
Statistical analysis was performed using GraphPad Prism
version 7.00 for Windows (GraphPad Software, La Jolla
California USA, www.graphpad.com). Data are mean ±
SD, representing three biological replicates, unless indi-
cated. Differences between time-points for the same
samples were analysed by the Student t-test, while differ-
ences between samples at different time points were an-
alyzed by one way ANOVA followed by Fisher’s Least
Significant Difference (LSD) Test.
Additional file
Additional file 1: Figure S1. pH of BCG co-cultures with LAB isolates or
E. coli and Salmonella after 0 (white bars), 24 (grey bars) and 48 (black bars)
h of incubation. Different letters signify statistical differences between mean
values using ANOVA followed by LSD (p < 0.05).
Figure S2. Viability (A) and survival rate (B) of BCG when grown as a
monoculture at pH 5 or pH 7 after 0 (white bars), 24 (grey bars) and 48
(black bars) h of incubation. Viability and survival rate are expressed as
log10 Fluorescence Units (FU) and log10 CFU/mL, respectively.
Figure S3. BCG viability when grown in cell-free supernatants from 48
h-cultures of enterococci (i), weissella (ii), lactobacilli (iii), pediococci (iv)
and gut-associated Gram-negative bacteria (v) after 0 (white bars), 24
(grey bars) and 48 (black bars) h of incubation. BCG viability is
expressed as log10 Fluorescence Units (FU).
Figure S4. Survival rate of BCG when grown in cell-free supernatants from
48 h-cultures of enterococci (i), weissella (ii), lactobacilli (iii), pediococci
(iv) and gut-associated Gram-negative bacteria (v) after 0 (white bars),
24 (grey bars) and 48 (black bars) h of incubation. BCG survival rate is
expressed as log10 CFU/mL.
Figure S5. Significant positive correlation between mean values of NF-κB
activation and TNFα production in PMA-differentiated THP-1 macrophages
exposed to inactivated bacterial strains and LPS, at a ratio of 1:100
(macrophage::bacteria) and 0.2 μg/μl, respectively (p < 0.0001).
Figure S6. Growth rate of enterococci (i), weissella (ii), lactobacilli (iii),
pediococci (iv) and gut-associated Gram-negative bacteria (v) after 0 (white
bars), 24 (grey bars) and 48 (black bars) h of incubation when co-cultured
with BCG. Growth rate is expressed as log10 CFU/mL. (DOCX 217 kb)
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